SCHEMBL24936175

SCHEMBL24936175

CC(C)(C)c1cncn1C1CCCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.41
HSP90AB1 P08238 2/20 0.41
IDO1 P14902 6/20 0.39
PIM1 P11309 1/20 0.38
MARK3 P27448 1/20 0.38
MAP4K2 Q12851 1/20 0.38
CAMK2B Q13554 1/20 0.38
PIM3 Q86V86 1/20 0.38
PIM2 Q9P1W9 1/20 0.38
TDO2 P48775 4/20 0.35
CYP19A1 P11511 3/20 0.34
PI4KA P42356 3/20 0.33
PI4K2B Q8TCG2 3/20 0.33
PI4K2A Q9BTU6 3/20 0.33
PI4KB Q9UBF8 3/20 0.33
ADORA2A P29274 2/20 0.33
ADORA3 P0DMS8 1/20 0.33
ADORA1 P30542 1/20 0.33
ALDH1A1 P00352 2/20 0.32
HCAR1 Q9BXC0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25857280 0.92 HSP90AA1 (0.40) HSP90AA1HSP90AB1IDO1PIM1MARK3
SCHEMBL24936176 0.76 TBXAS1 (0.37) HSP90AA1HSP90AB1IDO1PIM1MARK3
SCHEMBL27045780 0.76 HSP90AA1 (0.43) HSP90AA1HSP90AB1IDO1PIM1MARK3
SCHEMBL2262566 0.74 HSP90AA1 (0.46) HSP90AA1HSP90AB1IDO1PIM1MARK3
SCHEMBL27045457 0.72 HSP90AA1 (0.40) HSP90AA1HSP90AB1IDO1PIM1MARK3
SCHEMBL18250320 0.72 HSP90AA1 (0.50) HSP90AA1HSP90AB1IDO1PIM1MARK3
SCHEMBL2262558 0.71 IDO1 (0.43) HSP90AA1HSP90AB1IDO1PIM1MARK3
SCHEMBL18250245 0.70 HSP90AA1 (0.52) HSP90AA1HSP90AB1IDO1PIM1MARK3
SCHEMBL22939918 0.69 IDO1 (0.42) HSP90AA1HSP90AB1IDO1PIM1MARK3
SCHEMBL22940945 0.69 IDO1 (0.42) HSP90AA1HSP90AB1IDO1PIM1MARK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230022304-A1 WDR5-MYC INHIBITORS VANDERBILT UNIVERSITY 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230022304-A1 WDR5-MYC INHIBITORS MYC, WDR5, MYCBP HSP90AA1 1825/4885HSP90AB1 1688/4885IDO1 3646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.